Cardioxyl Pharmaceuticals engages in the discovery and development of therapies and technologies for the treatment of cardiovascular diseases.
Business Model:
Revenue: $0
Employees: 51-200
Cardioxyl was acquired by
Bristol Myers Squibb.
The acquisition happend on 2015-11-02.
Details of the transaction were not public
Address: 1450 Raleigh Rd
City: Chapel Hill
State: NC
Zip: 27517
Country: US
Cardioxyl Pharmaceuticals engages in the discovery and development of therapies and technologies for the treatment of cardiovascular diseases.
Contact Phone:
+19198698585
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2010 | Equity | $15M |
Aurora Funds New Enterprise Associates |
8/2009 | Venture Round | $9M | 10/2012 | Series B | $28.1M |
OrbiMed Advisors New Enterprise Associates The Aurora Funds |
11/2012 | Series B | 4 | $28M |
The Aurora Funds New Enterprise Associates OUP (Osage University Partners) OrbiMed OrbiMed The Aurora Funds New Enterprise Associates OUP (Osage University Partners) OrbiMed OrbiMed |
8/2010 | Venture Round | 2 | $15M |
The Aurora Funds New Enterprise Associates The Aurora Funds New Enterprise Associates |
12/2006 | Series A | 2 | $14.5M |
The Aurora Funds New Enterprise Associates New Enterprise Associates The Aurora Funds The Aurora Funds New Enterprise Associates New Enterprise Associates The Aurora Funds |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|